DOJOLVI

triheptanoin · Ultragenyx Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DOJOLVI, covering 2014-07-28 to 2023-10-30. Get the full timeline:

Most recent: FDA Approved: DOJOLVI — Supplemental Application (Ultragenyx Pharmaceutical Inc.)